MG Therapies' Incubator/Accelerator Round

MG Therapies raised a round of funding on July 25, 2017. Investors include evoNexus.

MG Therapies's delivers treatments for Dry Eye Syndrome and Meibomian Gland Dysfunction. The MGrx is an in-clinic table top device that delivers three clinical treatments (Lid Debridement, Gland Expre…

Articles about MG Therapies' Incubator/Accelerator Round: